Sign up to receive the latest updates

Contact Information

Tel: +44 1789 867523
Fax: +44 1789 450682
Email: info@heartrhythmcongress.org.uk

Heart Rhythm Congress
PO Box 3697
Stratford Upon Avon
Warwickshire
CV37 8YL
UK

Heart Rhythm Congress Facebook
Heart Rhythm Congress LinkedIn
Heart Rhythm Congress Twitter

Tuesday 11 October

To include 

AF OUTCOMES OUTSIDE THE LAB
AICC: DEBATE & CASE DISCUSSIONS
AICC: IMPORTANT ISSUES IN PAEDIATRICS & THE TRANSITION TO ADULT CARE
CARDIAC PHYSIOLOGIST MEETING 
CRM: COST EFFECTIVE APPROACHES TO IMPROVING SCD PATIENT OUTCOMES
DAILY DEVICE CHALLENGES
DEVICE MANAGEMENT: PALLIATIVE & END OF LIFE CARE
EP: REDEFINING ELECTROPHYSIOLOGY: SIGNAL QUALITY THAT MATTERS 
HEART RHYTHM TRAINEES - HOW TO…
IMPROVING ARRHYTHMIA MANAGEMENT (2)
MASTER CLASS DEVICES, PART 4 - DEVICE & LEAD ISSUES
MASTER CLASS DEVICES, PART 5
MASTER CLASS ON MAKING MORE PATIENTS RESPOND BETTER TO CRT
MODERATED POSTERS (2)
NOAC HOT TOPICS: TRANSLATING LATEST CLINICAL & CARDIOVERSION DATA INTO PRACTICE
ORAL ABSTRACTS 2
PLENARY SESSION - OPTIMUM ARRHYTHMIA PATIENT CARE - 2016 AND BEYOND
SYNCOPE AND POTS: MIND AND BODY 1
THE CASE FOR SCREENING FOR UNKNOWN AF TO PREVENT STROKE 
THE ZERO JARGON BASIC SCIENCE PRIMER: EVERYTHING YOU EVER WANTED TO KNOW ABOUT WHAT'S ACTUALLY GOING ON INSIDE YOUR PATIENT BUT WERE TOO AFRAID TO ASK

 


08:30-10:00 EP: Redefining Electrophysiology: Signal Quality that Matters - Supported by Boston Scientific - Hall 7 

08:30 Introduction
J Morgan
08:35 Demonstrating Rhythmia for Simple and Complex Ablations T Wong & B Lim London UK; London UK
09:15 Pace and Ablate with Mifi Ablation Mini Electrodes M Lovell Exeter UK
09:35 Getting the best from your Rhythmia System
A Yue
Southampton UK
09:55 Conclusion & Reflections
J Morgan
 
10:00 Close
   

 

08:30-10:00 Daily Device Challenges - Hall 8a 

Chair:  J Wright & A Zaidi   Liverpool UK; Manchester UK
08:30 At the time of investigations and procedures
a) MRI scanning
b) Peri-operative
 
H Thomas Northumbria UK
09:00 At the time of box change: device replacement/upgrades  A Rao Liverpool UK
09:30 Management of patients with suspected cardiac device infections  C Cunnington Manchester UK
10:00 Close    



08:30-10:00 Device Management: Palliative & End of Life Care - Hall 8b 

Chair: D Connelly & K Hogg
  Glasgow UK; Glasgow UK
08:30 Device management and generator changes towards end of life: 
What do we want to avoid?
S Pettit
Cambridge UK
08:50 What do we mean by palliative and end of life care:
 How does that help us identify patients for device management at that stage?
 
K Hogg Glasgow UK
09:15 Difficult conversations:  When is the right time & how
can we make those conversations easier?
  
M Johnson  Hull UK
09:35 What is the role of the anticipatory care and device deactivation plans? Y Millerick
 Glasgow UK
10:00 Close    



08:30-10:00 The Zero jargon Basic Science Primer: Everything you ever wanted to know about what's actually going on inside your patient but were too afraid to ask - Hall 9 

Chair:  M Finlay & G Morris
  London UK; Manchester UK
08:30 Truths and lies of the heart rate of your patient M Boyett
Manchester UK
08:50 Can "personalised medicine" work for my patients yet?  S Priori
 Pavia IT
09:05 Exercise is bad for your heart - and how to prevent it  A D'Souza
Manchester UK
09:25 How to survive questions about the action potential IN ANY EXAM EVER R Myles  Glasgow UK
09:40 You'll never believe how cardiac fat stops AF ablation from working! OMG! S Hatem
Paris UK
10:00 Close    

 

08:30-15:00 AF Outcomes Outside the Lab - Supported by AF Association - Hall 10   

Chair:  D Redfearn
  Kingston CA
08:30 Persistent AF ablation - Is it worth it? S Narayan Stanford US
09:00 Is AF preventable? The interplay between genetic and environmental factors in genesis of AF A Grace
Cambridge UK
09:30 Relationship between AF Burden and Stroke: is AF just a marker of increased thrombotic risk? D Fox
Manchester UK
10:00 Break followed by Plenary    
Chair: D Fox   Manchester UK
13:30 When to Stop Anticoagulation post AF ablation in patients with CHADSVASC score of >2? A Ng Leicester UK
14:00 Can the UK afford ablation for persistent AF? Cost efficacy analyses D Todd
Liverpool UK
14:30 Prevention of AF-related stroke: how would it change in the next 5 years? J Healey
Ontario CA
15:00 Close    



08:30-10:00 Cardiac Physiologist Meeting - Hall 11

Chair:  S Allen & J Sibley   Manchester UK; Basildon UK
08:30 BHRS - what's the future N Linker  Middlesbrough UK
09:00 STP/ HSST what does it mean for the current physiologist workforce? M Squirrell
London UK
09:30 Publishing a book/ e book on devices - A physiologists experience K Webb
Surrey UK
10:00 Close    

 

08:30-10:00 NOAC hot topics: Translating latest clinical and cardioversion data into practice - Supported by Daiichi Sankyo - Interactive Area, Hall 3 

Chair:  I Menown
  Belfast IR
08:30 Welcome and introduction I Menown
Belfast IR
08:35 Using NOACs in cardioversion - what's the latest evidence?
D Jones
London UK
08:55 Translating evidence into clinical decisions - which NOAC for which patient I Menown
Belfast IR
09:15 From principal to practice - a case study review C Varma
Birmingham UK
09:35 Q&A All  
09:55 Summary I Menown Belfast IR
10:00 Close    


10:45-12:15 Plenary Session - Optimum Arrhythmia Patient Care - 2016 and beyond - Hall 11 

Chair:  K Rajappan
  Oxford UK
10:45 Transforming heart rhythm management in 5 steps  R Schilling  London UK
11:05 Device Therapy - how to meet the challenges over the next 5-10 years  N Linker 
Middlesbrough
11:30 Gene therapy: a new approach to treatment in the genetic arrhythmia S Priori
Pavia IT
11:50 SCD risk in athletes  S Sharma  London UK
12:15 Close    



13:30-17:15 Oral Abstracts 2 - Hall 7

Chair: F Murgatroyd & T Wong
  London UK; London UK
  EP & Ablation    
13:30 CARDIAC ABLATION PATIENT REPORTED OUTCOMES MEASURES (PROMS): ANALYSIS OF POST-ABLATION AND 1 YEAR FOLLOW-UP DATA J Evans
Cardiff UK
13:45 INTENTIONAL CORONARY VEIN EXIT AND CARBON DIOXIDE INSUFFLATION TO ALLOW SAFE SUBXIPHOID EPICARDIAL ACCESS FOR VENTRICULAR MAPPING AND ABLATION - FIRST EXPERIENCE
J Silberbauer
Brighton UK
14:00 PACED FRACTIONATION DETECTION AS A TOOL FOR MAPPING SCARS IN VT D Redfearn
Kingston CA
14:15 DOES USE OF CONTACT-FORCE SENSING CATHETERS IMPROVE THE OUTCOME OF ABLATION OF VENTRICULAR TACHYCARDIA? A Kontogergis
London UK
14:30 RETROGRADE AORTIC ACCESS OF THE PULMONARY VENOUS ATRIUM PROVIDES EQUIVALENT OUTCOMES TO RIGHT ATRIAL OR TRANSEPTAL ACCESS OF THE LEFT ATRIUM IN PATIENTS WITH CONGENITAL HEART DISEASE V Ezzat London UK
14:45 COMPUTATIONAL THREE-DIMENSION LEFT ATRIAL APPENDAGE WALL THICKNESS MAPS AND HISTOLOGICAL ANALYSIS TO GUIDE LEFT ATRIAL APPENDAGE ELECTRICAL ISOLATION S Panikker London UK
15:00 Break    
Chair:  J Lee & A Morley-Davies
  Sheffield UK; Stoke on Trent UK
  Pacing & Devices    
15:45 IDENTIFYING THE OPTIMAL LOCATION FOR LV ENDOCARIDAL PACING:RESULTS FROM A MULTICENTRE INTERNATIONAL REGISTRY OF LV ENDOCARDIAL PACING B Sieniewicz London UK
16:00 UK MULTI-CENTRE REGISTRY OF TRANSVENOUS LEAD EXTRACTION: CLINICAL OUTCOME USING TRACTION, CUTTING SHEATHS AND LASER TECHNIQUES C Martin Cambridge UK
16:15 SKIN FISTULA FORMATION - A NEW EXPERIENCE WITH THE NEW TYRX ABSORBABLE ANTIMICROVIAL ENVELOPE M Burg Mside SP
16:30 BIFOCAL RIGHT VENTRICULAR PACING IN PATIENTS WITH FAILED CORONARY-SINUS LEAD IMPLANTS: LONG-TERM RESULTS FROM MULTICENTRE REGISTRY R Providencia London UK
16:45 REAL TIME X-MRI GUIDED LEFT VENTRICULAR LEAD IMPLANTATION FOR TARGETED DELIVERY OF CARDIAC RESYNCHRONIZATION THERAPY J Behar London UK
17:00 ACUTE AND CHRONIC PERFORMANCE OF COMMUNICATING LEADLESS ANTI-TACHYCARDIA PACEMAKER AND SUBCUTANEOUS IMPLANTABLE DEFIBRILLATOR M Burke Chicago US
17:15 Close    

 

13:30-15:00 CRM: Cost effective approaches to improving SCD patient outcomes - Supported by Boston Scientific - Hall 8a 

13:30 Delivering a safe and cost effective service for SCD with S-ICD
P Lambiase
London UK
13:55 The real world cost of device complications: A UK Experience
J Wright
Liverpool UK
14:20 Longevity cost saving impact from a hospital perspective
G Boriani
Modena IT
14:50 Q&A

15:00 Close    


13:30-17:15 Syncope & POTS: Mind & Body 1 - Hall 8b 

Chair:  N Gall & M Opie-Moran
  London UK
13:30 Welcome     
13:35 Clinical phenotyping of variants POTS and VVS V Iodice
London UK
14:15 Molecular phenotypes of POTS and VVS M Esler
Melbourne AU
14:40 Hot topic: antibodies and POTS A Fedorowski
Lund SW
15:00 Break
   
15:45 Mind-body interactions in POTS and VVS S Raj
Calgary CA
16:15 Cognitive/Attentional Profiles and Neuropathophysiology in PoTS and Syncope A Owens
London UK
16:45 The Practical Guide to POTS in the UK document N Gall London UK
17:15 Close    

13:30-15:00 Master Class Devices, Part 4 - Devices & Lead Issues - Hall 9 

Chair:  A Slade & M Squirrell   Truro UK; London UK
13:30 The ECG in device implant and follow up: How useful is it? P Moore Watford UK
14:00 Reducing device implant related complications - an implanters guide A Zaidi Manchester UK
14:30 Reducing device implant related complications - a physiologists guide S Allen Manchester UK
15:00 Close    


13:30-17:15 Improving Arrhythmia Management 2 - Supported by Arrhythmia Alliance - Hall 11 

Chair:  A Brandes
  Odense DK
13:30 Shared decision making in the management of arrhythmias - The case of AF Y Javaid
Northampton UK
14:00 Personalized arrhythmia management - from a physician's perspective A Grace Cambridge UK
14:30 Personalized arrhythmia management - from a patient's perspective T Lobban Stratford Upon Avon UK
15:00 Break
   
Chair:  D Gupta   Liverpool UK
15:45 The wearable defibrillator - State-of-the-Art HU Klein Magdeburg DE
16:15 Diagnosing AF using implantable devices A Brandes
Odense DK
16:45 Improving outcomes in out-of-hospital cardiac arrest (AED, resuscitation by laypersons) FL Henriksen Odense DK
17:15 Close    

 

 

13:30-15:00 AICC: Important Issues in Paediatrics & the Transition to Adult Care - Interactive Area 

Chair:  J Till & N Wheeldon         
  London UK; Sheffield UK
 
13:30 SIDS: Is it in the genes? L Wong London UK
 
13:50 How to manage the transition: psychological aspects K Ashcroft  Leeds UK
 
14:10 How to manage the transition: the channelopathies J Till
London UK
 
14:30 How to manage the transition: the cardiomyopathies M Tome-Esteban
London UK
 
14:50 The RASE Brugada study: National Registry E Behr London UK
 
15:00  Close
     

Registration fee - £35.00 (to attend AICC sessions only)*

If your payment hasn't been received before or on Friday 30 September 2016 your registration will become null and void and you will need to re-register.

*Does not include admission to exhibition for lunch and refreshments.

 

15:00-15:45 Moderated Posters (2) - Hall 3 Poster Area

Chair: M Finlay, London UK & A Yue, Southampton UK


15:45-17:15 The Case for Screening for Unknown AF to Prevent AF-Related Stroke - Supported by AF Association - Hall 8a

Chair: D Fitzmaurice & J Healey
   Birmingham UK; Ontario CA
15:45 Changes in epidemiology of AF, and incidence and prognosis of incidentally detected AF  J Harbison 
Dublin IR
16:15 Detection rates of unknown AF by screening  J Healey
Ontario CA
16:35 Response to treatment of incidentally detected AF  B Freedman
Sydney AU
16:55 Is AF screening cost effective L Ake Levin
Linkoping SE
17:15 Close     


15:45-17:15 Master Class Devices, Part 5 - Hall 9 

Chair:  S Allen   Manchester UK
Panel: D Begley, L Broadhurst & P Doherty
  Cambridge UK; Rotherham UK; Stratford Upon Avon UK
Interactive session Test your EGM knowledge vai the voting App    
15:45 EGM interpretation part 3 - case studies    
16:30 EGM interpretation part 4 - case studies    
17:15 Close    

 

15:45-17:15 Master Class on Making More Patients Respond Better to CRT - Supported by LivaNova - Hall 10 

Chair:  C Plummer & M Virdee
  Newcastle UK; Cambridge UK
15:45 Respond Study: The contribution of SonR to increasing Responder rates F Murgatroyd
London UK
16:10 RESPOND-CRT in practice
M Virdee
Cambridge UK
16:35 Multipoint automatic CRT optimisation dream or reality F Leyva
Birmingham UK
17:00 Round table debate    
17:15 Close    


15:45-17:15 AICC: Debate & Case Discussions - Interactive Area 

Chair:  C Garratt & T Homfray
  Manchester UK; London UK
15:45 Debate: This house believes that ALL Cardiologists should be ordering ALL genetic tests Pro: G Stuart
Con: S Mehta
Bristol UK; Cambridge UK
16:20 Rebuttal and vote    
Chair:  T Homfray & S Page
  London UK; Leeds UK
  Case discussions in the ICCs (10 mins each)*

16:30 Saving private Ryan A Varnava London UK
16:40 AF with worrying undercurrents A Kontogeorgis London UK
16:50 Heart Block with Red Flags B Ensam London UK
17:00 A case of sudden cardiac death; an unexpected finding S Papatheodorou London UK
17:15 Close    

*If you would like to present your ICC related case during this session, please send a 100 word synopsis of your cases describing the main points of interest to webmaster@theaicc.org

Registration fee - £35.00 (to attend AICC sessions only)*

If your payment hasn't been received before or on Friday 30 September 2016 your registration will become null and void and you will need to re-register.

*Does not include admission to exhibition for lunch and refreshments.

 

17:30-19:00 Heart Rhythm Trainees - How to... - Hall 8a 

Chair:  A Opel   London UK
17:30 How to get that perfect consultant job: what to do and how to write the perfect CV R Hunter London UK
17:50 How to prepare for the consultant interview: what to expect and how to shine  M Lovell
Exeter UK
18:05 How to launch an academic career in electrophysiology M Finlay  London UK
18:25 How to tailor your skills to electrophysiology of the future S Furniss
Eastbourne UK
18:40 How to be a better leader  M Lowe
 
London UK
19:00 Close     

Endorsed By